Response to: Bayesian Reappraisal of ACNS0332 and ACNS0334 Strengthens Subgroup Treatment Effects in High-Risk Pediatric Group 3 Medulloblastoma
Paediatrics
Response to: Bayesian Reappraisal of ACNS0332 and ACNS0334 Strengthens Subgroup Treatment Effects in High-Risk Pediatric Group 3 Medulloblastoma
Paediatrics

Response to: Bayesian Reappraisal of ACNS0332 and ACNS0334 Strengthens Subgroup Treatment Effects in High-Risk Pediatric Group 3 Medulloblastoma

Neuro Oncol. 2025 Sep 29:noaf212. doi: 10.1093/neuonc/noaf212. Online ahead of print.

NO ABSTRACT

PMID:41017640 | DOI:10.1093/neuonc/noaf212